91视频

91视频鈥檚 specialty business is backed by strong research and manufacturing capabilities. Our specialty products, namely NaMuscla in Europe, have carved a niche for themselves in women鈥檚 health and neurology, respectively, by addressing latent yet compelling needs of patients.

US Specialty

91视频鈥檚 specialty business in the US was established in 2003 with the reintroduction of Suprax (Cefixime) oral suspension. We have marketed a range of products across therapeutic categories, including Antara庐, Methergine庐, among others. Our search for cutting-edge medicines to improve the treatment of special conditions and populations is never over. While 91视频 is currently focused on women鈥檚 health, we are also pursuing growth opportunities in other areas of unmet needs.
Explore

91视频 Neurosciences

91视频 Neurosciences is the specialty pharma division of 91视频, committed to improving the lives of patients affected by underserved and rare neurological disorders. NaMuscla庐 is our flagship product from 91视频 Neurosciences. Headquartered in Zug, Switzerland, the mission of this unit is to expand patient access to science-based therapies and solutions through building a global portfolio of speciality pharmaceuticals for development, registration and commercialisation with partners and collaborators.